Charite University, Berlin, Germany clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-19
What changed in the last 30 days
16 trials changed in the last 30 days: 0 stopped, 6 with notable changes, 10 with minor changes only.
- Notable: Stroke-CORE · Master Study Protocol for the Cohort of the Specialty Network Stroke (SN Stroke) Recruitment opened
- Minor: Reduction of Blood Recirculation in Veno-Venous ECMO Trial completed
-
Minor: 2 trials marked Unknown by the registry's verification sweep Changed
- Minor: BioBone · Validation Study of the CD8+TEMRA Cells As a Prognostic Biomarker of Healing Outcome After Fracture Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Recruiting
- Minor: LONGitudinal Multi-omics Phenotyping of KIDney Function Alteration Changed Registry marked status Unknown (sponsor has not verified the record since Jun 2024); last known: Recruiting
- Minor: Pro-Health · Impact of Propionic Acid on Regulatory T Cell Function in Healthy Adults ( Pro-Health) Study completion pushed from May 30, 2025 to Jan 30, 2027
- Notable: Pro-Kids · Impact of Propionic Acid on Regulatory T Cell Function · CKD Primary completion date changed from estimate of Sep 2025 to Jul 8, 2026
- Minor: GETREADY · Preoperative Preparation in Children Undergoing Cardiac Surgery or Catheterization Trial completed
- Notable: STASS · Surgical Treatment of Adjacent Segment Stenosis Recruitment opened
- Notable: Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020) Recruitment opened
- Minor: Digitalized Clinical Decision Support · Postoperative Delirium (POD) Trial completed
- Notable: BIO-AD · Microbiome in Atopic Dermatitis Under Systemic Therapy Primary and study completion pushed from Dec 31, 2025 to Dec 31, 2026
- Minor: AD-Sys · Extrinsic and Intrinsic Factors in Atopic Dermatitis Upon Systemic Immune Modulation Trial completed
- Minor: EPAP, Interviewstudy Enrollment closed, study ongoing
- Notable: ATAC · Atopy Network - Comprehensive Allergy Centers: Medical Care · Moderate to Severe Allergic Diseases Primary and study completion pushed from Aug 31, 2025 to Dec 31, 2027
- Minor: AI-OCS-Gyn · Ovarian Cancer Screening and AI Completed without a posted recruiting period
- Minor: Integrating Olfactory Stimuli Into Virtual Reality Cue Exposure · Alcohol Dependence Trial completed
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
New trial filings, last 30 days
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-11-09 | NCT07924722 Local Iloprost Therapy to Promote Bone Healing in High Risk Fractures | Phase 2 | Not Yet Recruiting |
| 2026-11-06 | NCT07921121 Assessment of Communication Interventions on Vaccination Knowledge and Acceptance | Recruiting | |
| 2026-10-27 | NCT07897110 AI-generated Treatment Recommendations in Precision Oncology | Recruiting |
Active trials by phase
| Phase 1/2 | 3 | |
| Phase 2 | 6 | |
| Phase 3 | 3 | |
| Phase 4 | 2 |
Not charted: 88 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).
Disease areas by active trials, top 10 of 41
Heart Disease (10) · Colorectal Cancer (5) · Depression (3) · Multiple Sclerosis (3) · Prostate Cancer (3) · Psoriasis (3) · Psoriatic Arthritis (3) · Schizophrenia (3) · Acute Lymphoblastic Leukemia (ALL) (2) · Ankylosing Spondylitis (2)
Get alerts when Charite University, Berlin, Germany's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.